| 2026-08-11 | Press release | LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights |
| 2026-08-04 | Press release | LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026 |
| 2026-07-06 | Press release | LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ® for the Tr |
| 2026-06-24 | Press release | LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Au |
| 2026-06-07 | Press release | LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater Chi |
| 2026-05-26 | Press release | LENZ Therapeutics to Participate in Upcoming Investor Conferences |
| 2026-05-26 | Press release | Download as PDF |
| 2026-05-11 | Press release | LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights |
| 2026-05-11 | Press release | PDF |
| 2026-05-04 | Press release | LENZ Therapeutics to Report First Quarter 2026 Financial Results and Recent Corporate Highlights on May 11, 2026 and Att |
| 2026-04-20 | Press release | LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products R |
| 2026-03-24 | Press release | LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights |
| 2026-03-24 | Press release | PDF |
| 2026-03-24 | Press release | PDF |
| 2026-03-17 | Press release | LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March |
| 2026-03-10 | Press release | LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for |
| 2026-01-14 | Press release | LENZ Therapeutics and Sarah Jessica Parker announce the launch of “Make it VIZZable”, the VIZZ consumer campaign |
| 2026-01-07 | Press release | LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates |
| 2025-11-05 | Press release | PDF |
| 2025-07-30 | Press release | PDF |
| 2025-05-07 | Press release | PDF |
| 2025-05-06 | Press release | LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference |
| 2025-03-19 | Press release | LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights |
| 2025-03-19 | Press release | PDF |
| 2025-03-11 | Press release | LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March |
| 2025-03-03 | Press release | LENZ Therapeutics to Host Commercial Day on April 15, 2025 |
| 2024-11-06 | Press release | PDF |
| 2024-10-30 | Press release | LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024 |
| 2024-08-14 | Press release | PDF |
| 2024-08-14 | Press release | LENZ Therapeutics Reports Second Quarter 2024 Financial Results |
| 2024-08-07 | Press release | LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024 |
| 2024-06-10 | Press release | LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024 |
| 2024-05-30 | Press release | LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference |
| 2024-05-08 | Press release | PDF |
| 2024-05-08 | Press release | LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates |
| 2024-05-01 | Press release | LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024 |
| Presentation | Key Opinion Leader Presentation of Capstone Data from Phase 3 CLARITY Study |
| Press release | LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials |